The other aspect of this is awareness.... PIQ is majorly flying under the radar, in both the investment community and the medical space.
This collaboration exposes PIQ to both.
For PromarkerD to become the worldwide standard, it has to pass through the "Big Parma" process. This will not happen overnight, but this is the first major step.
Its one thing to build a test that bypasses big pharma, but its far better to do it with them.... why smash down the door, when the door man invites you in?
Ann: Proteomics signs PromarkerD agreement with US big pharma, page-24
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $62.19M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.0¢ | 36.0¢ | $53.71K | 143.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 491 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 39195 | 2 |
View Market Depth
| Last trade - 15.55pm 07/08/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |